Downloads: 705

Files in This Item:
File Description SizeFormat 
KJ00000132760.pdf555.81 kBAdobe PDFView/Open
Title: タイ国における結核の現状 : 結核化学療法の立場から
Other Titles: The Present Status of Pulmonary Tuberculosis in Thailand from the Viewpoint of Tuberculosis Chemotherapy
Authors: 前川, 暢夫  KAKEN_name
Author's alias: Maekawa, Nobuo
Issue Date: Jun-1965
Publisher: 京都大学東南アジア研究センター
Journal title: 東南アジア研究
Volume: 3
Issue: 1
Start page: 95
End page: 104
Abstract: It is estimated that in Thailand there are over 1, 200, 000 (about 4% of population) pulmonary tuberculsis patients to be treated, 300, 000 to 400, 000 patients among them with cavitary lesions or far-advanced lesions and at least 300, 000 patients with sputum positive for tubercle bacilli. From 1960, the tuberculosis control program of Thailand (especially of Bangkok) has been developed mainly in the field of mass-ambulatory-chemotherapy by sheer efforts of the staffs of Tuberculosis Control Division (Central Chest Clinic) supported by WHO and UNICEF. They are administering daily 0.3g. of isoniazid (INH) plus 10g. of PAS-Na or 0.15g. of TBl. Streptomycin (SM) is used in very few cases chiefly due to its expense. In fact, they have not more than 500 hospital beds for the isolation and the treatment of tuberculosis patients in Bangkok (Central Chest Hospital) and that is all in the whole Thailand now. So the most of the patients should be treated ambulatory. In spite of such severe social circumstances in Thailand, the effort seems to have been rewarded with good fruit. The author, however, wants to know whether there might be much more efficacious chemotherapeutic regimen suitable for ambulatory treatment. Concerning tuberculosis generally in Asian developing countries, it is one of the important tasks for Japanese doctors to investigate the most efficacious regimen of tuberculosis chemotherapy available to the ambulatory treatment. For this purpose, we must know at first about the results of the sensitivity tests against the prevailing tuberculostatic agents in all cases positive for tubercle bacilli. Then the results may directly reflect the effects of the regimens which they are using in Thailand and make it possible to evaluate the efficacy. We have planned to intensify the chemotherapeutic regimens in the original and re-treatment of pulmonary tuberculosis, and at present, we have some data (experimental and clinical) about the intensification of the regimens. The author believes that the chemotherapy of pulmonary tuberculosis in Thailand should be much more intensified in a realistic way. It is the best way in our field to make some contribution to the public health problem of Thai people.
Description: この論文は国立情報学研究所の学術雑誌公開支援事業により電子化されました。
URI: http://hdl.handle.net/2433/55041
Appears in Collections:Vol.3 No.1

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.